Insulin and Insulin Pulses During Fasting
Recruiting now · Not applicable
Conditions studied: PreDiabetes
In brief
Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is known about the regulation of glucose concentrations in the fasting state relative to what is known about the postprandial state. The proposed experiment is part of a series of experiments designed to establish how glucagon and insulin interact with their receptors to control fasting glucose in health and in prediabetes.
Key facts
- Study ID
- NCT06424015
- Run by
- Mayo Clinic
- People needed
- 60
- Starts
- 2024-09-15
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2025-10-01
Who can join
Age: 25 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- people with normal or impaired fasting glucose and normal or impaired glucose tolerance
You may not qualify if…
- HbA1c > 6.5%
- BMI ≥ 35 Kg/M2
- Use of any glucose-lowering agents including metformin or sulfonylureas.
- For female subjects: positive pregnancy test at the time of enrollment or study
- History of prior upper abdominal surgery such as adjustable gastric banding, pyloroplasty and vagotomy.
- Active systemic illness or malignancy.
- Symptomatic macrovascular or microvascular disease.
- Hematocrit < 35%
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.